Related Experiment Video
Updated: May 29, 2026

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Pathology of calcific aortic stenosis
Elena Ladich1, Masataka Nakano, Naima Carter-Monroe
1CVPath, Institute Inc, Gaithersburg, MD 20878, USA.
Insights
Calcific aortic stenosis (CAS) is a growing concern in aging populations, often linked to bicuspid aortic valves (BAV) or tricuspid valve disease. Understanding the exact causes of this progressive condition remains a key challenge for effective treatment.
Area of Science:
- Cardiovascular Medicine
- Gerontology
- Pathology
Background:
- Calcific aortic stenosis (CAS) is a significant health issue due to the aging population in industrialized nations.
- CAS presents with a spectrum of pathologies, from valvular sclerosis to severe calcification.
- Common causes include calcific aortic valve disease in tricuspid valves and bicuspid aortic valve (BAV) abnormalities.
Purpose of the Study:
- To explore the underlying causes and pathological mechanisms of calcific aortic stenosis.
- To highlight the link between CAS and atherosclerosis risk factors.
- To address the need for better understanding of CAS pathogenesis.
Main Methods:
- Review of current literature on calcific aortic stenosis.
- Analysis of etiological factors related to age and valve morphology (tricuspid vs. bicuspid).
- Comparison of mechanistic similarities between CAS and atherosclerosis.
Main Results:
- CAS is age-dependent, with BAV being a significant etiological factor.
- The disease progresses pathologically from sclerosis to severe calcification.
- Atherosclerotic risk factors are associated with CAS, suggesting shared mechanisms.
Conclusions:
- The precise pathological mechanisms of CAS are not fully understood.
- Aortic valve replacement is the standard treatment for severe CAS, but tissue valves may calcify.
- Further research is needed to elucidate the pathogenesis of CAS.
Abstract:
With the aging of the general population in industrialized nations, calcific aortic stenosis (CAS) is becoming an increasingly important medical problem. The etiology is for the most part, dependent on the age at presentation; the two predominant causes in the western world are calcific aortic valve disease arising in a tricuspid aortic valve and bicuspid aortic valve (BAV). CAS is a progressive disease, exhibiting a spectrum of pathologic findings, ranging from valvular sclerosis to severe nodular calcification. Aortic valve replacement is the recommended treatment for severe disease but tissue valves may also calcify over time. Various atherosclerotic risk factors have been linked to aortic stenosis and there are mechanistic similarities between atherosclerosis and CAS. The precise pathologic mechanisms underlying aortic stenosis are poorly understood.
Related Concept Videos
Mitral Stenosis I: Introduction
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation I: Introduction
Peripheral Artery Disease I: Introduction

